The findings, presented at the annual meeting of the American Academy of Pediatrics in October, analyzed 84 patients aged 21 or younger diagnosed with colorectal cancer between 2012 and 2023. The median age at diagnosis was 16, and the median duration of symptoms before diagnosis was just 12 weeks. Only about 20% of patients had a close relative with the disease, indicating that hereditary factors are not the primary driver for most young patients.
Eighty percent of study participants were diagnosed at Stage III or IV, meaning the cancer had already spread locally or to distant organs by the time it was found. By comparison, across all age groups, 60% of colorectal cancer patients are diagnosed at those advanced stages, according to the CDC. One-third of the patients in the study also had cellular markers of particularly aggressive cancer.
Dr. Christopher Lieu, a professor of medical oncology at the University of Colorado Anschutz and medical adviser to the Colorectal Cancer Alliance, said the rise likely stems from environmental factors. “Most of the research has really focused on the gut microbiome,” Lieu told Live Science. He noted that microbiome disruptions may spur inflammation, which can trigger DNA mutations that cause cancer, but added that “it’s going to be extraordinarily more complex than that.”
Potential contributors include ultraprocessed foods, antibiotic exposure in childhood, stress, and reduced exercise. A specific variant of the common gut bacterium E. coli is strongly associated with colorectal cancer, but it does not explain all cases. “It may be a combination of food, antibiotic use and environmental exposures,” Lieu said.
Dr. Erica Arnold, a pediatric surgery research fellow at Nationwide Children’s Hospital who presented the study, said symptoms that warrant attention in young people include back and abdominal pain (reported by 75% of patients), changes in bowel movements (45%), unexplained weight loss (43%), and rectal bleeding (38%). While these symptoms often have more common causes, Arnold stressed that persistent or worsening gastrointestinal issues, especially weight loss or blood in the stool, should prompt a medical checkup. “It’s just important to investigate it to make sure we’re catching colorectal cancer earlier rather than later in these patients,” she said.
Lieu called the disease an “extraordinarily rare event” in children but said the data suggest that these cancers may be developing differently in young people. “If you want my honest opinion, it does suggest that these cancers are developing differently,” he said.
